Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 1,301–1,400 of 2,883
Voisin, J., Farina, F., Naphade, S. B., Fontaine, M., Tshilenge, K., Aguirre, C. G., Lopez‐Ramirez, A., Dancourt, J., Ginisty, A., Nair, S. S., et al. (2020) · Aging Cell · doi:10.1111/acel.13226 · Cited by 25
Naismith, E., & Pangrazzi, L. (2019) · Bioscience Reports · doi:10.1042/bsr20190371 · Cited by 25
Targeting immunosenescence for improved tumor immunotherapy
Liu, Z., Zuo, L., Zhou, Z., Liu, S., Ba, Y., Zuo, A., Ren, Y., Zhang, C., Chen, Y., Ma, H., et al. (2024) · MedComm · doi:10.1002/mco2.777 · Cited by 29
“66 67–69 However, it also secretes pro-inflammatory substances such as IL-6, IL-8, membrane cofactor proteins, and macrophage inflammatory proteins, which could increase proliferation, angiogenesis, and inflammation thereby having unfavorable implications.”
BackgroundSakai, T., Kurokawa, R., Hirano, S., & Imai, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020456 · Cited by 27
Out with the old, in with the new: senescence in development
Czarkwiani, A., & Yun, M. H. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.05.014 · Cited by 24
Mechanisms of Senescence and Anti-Senescence Strategies in the Skin
Konstantinou, E. K., Longange, E., & Kaya, G. (2024) · Biology · doi:10.3390/biology13090647 · Cited by 35
“The clearance of p16Ink4a-expressing cells in BubR1-hypomorphic progeroid mice delays aging-associated disorders [150,157], and the results of other studies suggested that elimination or weakening of the function of senescent cells may be a promising approach for the modulation of fundamental aging…”
BackgroundA new clinical age of aging research
Zhang, Z., Yang, R., Zi, Z., & Liu, B. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.08.004 · Cited by 28
“Remarkably, eliminating p16-positive senescent cells using a suicide gene-controlled strategy in mice was shown to delay some age-related disorders and increase the animals ’ median lifespan [10,11].”
Han, Y., Zhou, C., Shen, H., Tan, J., Dong, Q. D., Zhang, L. J., McGowan, S. J., Zhao, J., Sowa, G., Kang, J. D., et al. (2020) · Aging Cell · doi:10.1111/acel.13162 · Cited by 27
Graves, S. I., Meyer, C. F., Jeganathan, K. B., & Baker, D. J. (2025) · Neuron · doi:10.1016/j.neuron.2025.04.020 · Cited by 27
Self-citationTakaya, K., Ishii, T., Asou, T., & Kishi, K. (2022) · Aging · doi:10.18632/aging.204391 · Cited by 26
Senescence chips for ultrahigh‐throughput isolation and removal of senescent cells
Chen, Y., Mao, P., Snijders, A. M., & Wang, D. (2018) · Aging Cell · doi:10.1111/acel.12722 · Cited by 25
Latorre, E., Pilling, L. C., Lee, B. P., Bandinelli, S., Melzer, D. R., Ferrucci, L., & Harries, L. W. (2018) · Clinical Science · doi:10.1042/cs20171556 · Cited by 28
Zheng, X., Wang, Q., Xie, Z., & Li, J. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111313 · Cited by 23
The cell cycle regulator protein P16 and the cellular senescence of dental follicle cells
Morsczeck, C. O., Hullmann, M. M., Reck, A., & Reichert, T. E. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3134-6 · Cited by 25
Senescence: An Identity Crisis Originating from Deep Within the Nucleus
Olan, I., & Narita, M. (2022) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-120420-013537 · Cited by 25
Suzuki, Y., Hayashi, K., Goto, F., Nomura, Y., Fujimoto, C., & Makishima, M. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02139-4 · Cited by 30
Wei, Z., Guo, H., Qin, J., Lu, S., Liu, Q., Zhang, X., Zou, Y., Gong, Y., & Shao, C. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.457 · Cited by 24
Ishaq, A., Schröder, J., Edwards, N., von Zglinicki, T., & Saretzki, G. C. (2017) · The journal of nutrition health & aging · doi:10.1007/s12603-017-0968-2 · Cited by 28
Wallis, R., Josipović, N., Mizen, H., Robles‐Tenorio, A., Tyler, E. J., Papantonis, A., & Bishop, C. L. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12041 · Cited by 25
Raman fingerprints as promising markers of cellular senescence and aging
Liendl, L., Grillari, J., & Schosserer, M. (2019) · GeroScience · doi:10.1007/s11357-019-00053-7 · Cited by 24
Adili, A., Zhu, X., Cao, H., Tang, X., Wang, Y., Wang, J., Shi, J., Zhou, Q., & Wang, D. (2022) · Aging and Disease · doi:10.14336/ad.2021.0619 · Cited by 26
Garay, R. P. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1939306 · Cited by 29
Senescence and Aging: Does It Impact Cancer Immunotherapies?
Maggiorani, D., & Beausejour, C. M. (2021) · Cells · doi:10.3390/cells10071568 · Cited by 25
Regulatory Mechanisms of Mitochondrial Function and Cardiac Aging
Lin, R., & Kerkelä, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041359 · Cited by 27
The effect of age on stem cell function and utility for therapy
Narbonne, P. (2018) · Cell Medicine · doi:10.1177/2155179018773756 · Cited by 33
Chen, J., Zhang, W., Chen, K.-H., Lin, L.-R., Dai, H., Li, K., Zhang, J., Zheng, L., Fu, B.-Q., & He, Y. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00689.2016 · Cited by 24
Induction, regulation and roles of neural adhesion molecule L1CAM in cellular senescence
Mrázková, B., Dzijak, R., Hornofova, T., Kyjacová, L., Baráth, P., Džubák, P., Holub, D., Hajdúch, M., Nahácka, Z., Anděra, L., et al. (2018) · Aging · doi:10.18632/aging.101404 · Cited by 29
Senescence in chronic allograft nephropathy
Peña, M. D. P. S., Lopez‐Soler, R. I., & Melendez, J. A. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00195.2016 · Cited by 26
Fang, C., Zeng, Z., Ni, B., Wen, X., Fang, Z., Zou, J., & Zhang, G. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1681875 · Cited by 35
The interplay between cell death and senescence in cancer
Shimizu, K., Inuzuka, H., & Tokunaga, F. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.11.001 · Cited by 30
Rejuvenation by Therapeutic Elimination of Senescent Cells
Krimpenfort, P., & Berns, A. J. M. (2017) · Cell · doi:10.1016/j.cell.2017.03.014 · Cited by 25
Aprahamian, I., Mamoni, R. L., Cervigne, N. K., Augusto, T. M., Romanini, C. V., Petrella, M., da Costa, D. L., Lima, N. A., Borges, M. K., & Voshaar, R. C. O. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02963-9 · Cited by 29
Unbalanced Growth, Senescence and Aging
Polymenis, M., & Kennedy, B. K. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-57127-0_8 · Cited by 26
Aging, Plasminogen Activator Inhibitor 1, Brain Cell Senescence, and Alzheimer's Disease.
Jiang, C., Rana, T., Jin, L., Farr, S. A., Morley, J. E., Qin, H., Liu, G., & Liu, R.-M. (2023) · PubMed Central · doi:10.14336/ad.2022.1220 · Cited by 23
“It has been well documented that the number of senescent cells increases with age and in aging-related diseases, including AD [1, 3-8, 38-40].”
BackgroundBientinesi, E., Ristori, S., Lulli, M., & Monti, D. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111957 · Cited by 26
“%) of senescent cells can prevent ARDs and extend healthspan (Baker et al., 2011; Ogrodnik et al., 2017; Pignolo et al., 2021; Roos et al., 2016; Xu et al., 2015).”
BackgroundInfluentialNeault, M., Couteau, F., Bonneau, É., Guire, V. D., & Mallette, F. A. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.04.001 · Cited by 23
Understanding cellular senescence: pathways involved, therapeutics and longevity aiding
Kumar, A., & Thirumurugan, K. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2287929 · Cited by 31
“Meanwhile, removing senescent cells improved the quality of life in aged mice by arresting senescence-associated deterioration [80].”
BackgroundGünther, J., Resch, T., Hackl, H., Sattler, A., Ebner, S., Ritschl, P. V., Biebl, M., Öllinger, R., Schneeberger, S., Brandacher, G., et al. (2017) · Kidney International · doi:10.1016/j.kint.2016.12.018 · Cited by 24
The tumor suppression theory of aging
Wolf, A. M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111583 · Cited by 30
Senescence and Type 2 Diabetic Cardiomyopathy: How Young Can You Die of Old Age?
Henson, S. M., & Aksentijević, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716517 · Cited by 25
Cell Replacement to Reverse Brain Aging: Challenges, Pitfalls, and Opportunities
Hébert, J. M., & Vijg, J. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.02.008 · Cited by 25
New Horizons in cellular senescence for clinicians
Witham, M. D., Granic, A., Miwa, S., Passos, J. F., Richardson, G. D., & Sayer, A. A. (2023) · Age and Ageing · doi:10.1093/ageing/afad127 · Cited by 26
“This landmark proof-of-concept work shows that preventing or reversing senescence may be a viable strategy to counteract ageing and age-related disease [50, 70].”
BackgroundHatzmann, F. M., Ejaz, A., Wiegers, G. J., Mandl, M., Brucker, C., Lechner, S., Rauchenwald, T., Zwierzina, M., Baumgarten, S., Wagner, S., et al. (2021) · Cells · doi:10.3390/cells10020214 · Cited by 26
Liu, S., Zhang, G., Li, N., Wang, Z., & Lu, L. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s489613 · Cited by 29
“37,38 During cellular senescence, lipid droplets increase due to enhanced incorporation of exogenous lipids into triacylglycerols and elevated levels of free polyunsaturated fatty acids (PUFAs), driven by p38-dependent PLA2G1B activation.”
Takaya, K., Ishii, T., Asou, T., & Kishi, K. (2023) · Rejuvenation Research · doi:10.1089/rej.2022.0048 · Cited by 27
The role of cardiomyocyte senescence in cardiovascular diseases: A molecular biology update
He, S., Li, Y., Yuan, C., Li, W., Tian, W., Chen, S., Li, N., Wu, M., & Jiang, J. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176961 · Cited by 25
Ask, T. F., Lugo, R. G., & Sütterlin, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00726 · Cited by 24
The use of geroprotectors to prevent multimorbidity: Opportunities and challenges
Morsli, S., & Bellantuono, I. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111391 · Cited by 28
High dietary protein and fat contents exacerbate hepatic senescence and SASP in mice
Nehme, J., Yang, D., Altulea, A., Varela-Eirín, M., Wang, L., Hu, S., Wu, Y., Togo, J., Niu, C., Speakman, J. R., et al. (2021) · FEBS Journal · doi:10.1111/febs.16292 · Cited by 25
Huang, C.-Y., Chen, S.-H., Lin, T., Liao, Y., Chang, Y., Chen, C., Yu, C., & Chen, C. (2023) · Journal of Dental Sciences · doi:10.1016/j.jds.2023.10.016 · Cited by 27
Hoare, M., & Narita, M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-89512-3_15 · Cited by 24
Miyagi, Y., Kondo, Y., Kusuda, Y., Hori, Y., Yamazaki, S., Munemasa, T., Mukaibo, T., Masaki, C., & Hosokawa, R. (2019) · Biogerontology · doi:10.1007/s10522-019-09797-3 · Cited by 23
Cellular senescence and frailty: a comprehensive insight into the causal links
Marcozzi, S., Bigossi, G., Giuliani, M. E., Giacconi, R., Piacenza, F., Cardelli, M., Brunetti, D., Segala, A., Valerio, A., Nisoli, E., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00960-w · Cited by 28
Impact of Environmental and Epigenetic Changes on Mesenchymal Stem Cells during Aging
Smith, N., Shirazi, S., Cakouros, D., & Gronthos, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076499 · Cited by 26
The planaria Schmidtea mediterranea as a model system for the study of stem cell biology
Kipshidze, M., & Tqemaladze, J. (2023) · JUNIOR RESEARCHERS · doi:10.52340/2023.01.01.20 · Cited by 63
Anthracycline-induced cardiotoxicity and senescence
Booth, L. K., Redgrave, R. E., Folaranmi, O., Gill, J. H., & Richardson, G. D. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.1058435 · Cited by 27
Mechanisms of cancer stem cell senescence: Current understanding and future perspectives
Zhang, D., Monteiro, M. J., Liu, J., & Gu, W. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13528 · Cited by 27
Podocyte injury at young age causes premature senescence and worsens glomerular aging
Pereira, B. M. V., Zeng, Y., Maggiore, J. C., Schweickart, R. A., Eng, D. G., Kaverina, N. V., McKinzie, S. R., Chang, A., Loretz, C. J., Thieme, K., et al. (2023) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00261.2023 · Cited by 25
Tick-Tock Chimes the Kidney Clock – from Biology of Renal Ageing to Clinical Applications
Rowland, J., Akbarov, A., Maan, A., Eales, J., Dormer, J., & Tomaszewski, M. (2018) · Kidney & Blood Pressure Research · doi:10.1159/000486907 · Cited by 28
The Dynamic Process and Its Dual Effects on Tumors of Therapy-Induced Senescence
Liao, C., Xiao, Y., & Liu, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s285083 · Cited by 26
Role of low-dose radiation in senescence and aging: A beneficial perspective
Xu, J., Liu, D., Zhao, D., Jiang, X. M., Meng, X., Jiang, L., Meina, Y., Zhang, L., & Jiang, H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120644 · Cited by 32
Serrano, M., & Barzilai, N. (2018) · Nature Medicine · doi:10.1038/s41591-018-0141-4 · Cited by 23
Donor and Recipient Age-Mismatches: The Potential of Transferring Senescence
Iske, J., Matsunaga, T., Zhou, H., & Tullius, S. G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.671479 · Cited by 24
Gilbert, H. T. J., & Swift, J. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.03.002 · Cited by 23
Lee, H. J., Donati, A., Féliers, D., Sun, Y., Ding, Y., Madesh, M., Salmon, A. B., Ikeno, Y., Ross, C. N., O'Connor, C. L., et al. (2021) · Aging Cell · doi:10.1111/acel.13407 · Cited by 24
Endothelial senescence mediates hypoxia-induced vascular remodeling by modulating PDGFB expression
Kyi, P., Hendee, K., Hunyenyiwa, T., Matus, K., Mammoto, T., & Mammoto, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.908639 · Cited by 27
“Senescent ECs play a key role in vascular aging and agerelated cardiovascular and degenerative diseases (12, 13, 15), and senolytic reagents are extensively studied in the aging research (28, 29).”
BackgroundOrganismal Aging and Oxidants beyond Macromolecules Damage
Clement, M., & Luo, L. (2020) · PROTEOMICS · doi:10.1002/pmic.201800400 · Cited by 23
Senescence and senolysis in cancer: The latest findings
Imawari, Y., & Nakanishi, M. (2024) · Cancer Science · doi:10.1111/cas.16184 · Cited by 26
Role of epigenetics in the regulation of skin aging and geroprotective intervention: A new sight
Pozzo, L. D., Xu, Z., Lin, S., Wang, J., Wang, Y., Enechojo, O. S., Abankwah, J. K., Peng, Y., Chu, X., Zhou, H., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116592 · Cited by 26
SMARCA4 regulates the NK-mediated killing of senescent cells
Reen, V., D’Ambrosio, M., Søgaard, P. P., Tyson, K., Leeke, B. J., Clément, I., Dye, I. C., Pombo, J., Kuba, A., Lan, Y., et al. (2025) · Science Advances · doi:10.1126/sciadv.adn2811 · Cited by 33
“Consequently, their selective elimination positively affects life span and health span ( 56 ).”
Comparative Analysis of drugs that improve the Quality of Life and Life Expectancy
Kipshidze, M., & Tqemaladze, J. (2023) · JUNIOR RESEARCHERS · doi:10.52340/2023.01.01.19 · Cited by 65
Dynamic Aging: Channeled Through Microenvironment
Tan, Q., Liang, N., Zhang, X., & Li, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.702276 · Cited by 28
Malcomson, F. C., & Mathers, J. C. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-2835-0_13 · Cited by 26
New mechanisms driving muscle stem cell regenerative decline with aging
Sousa‐Victor, P., García‐Prat, L., & Muñoz‐Cánoves, P. (2018) · The International Journal of Developmental Biology · doi:10.1387/ijdb.180041pm · Cited by 23
The Double-Edged Role of Extracellular Vesicles in the Hallmarks of Aging
Romero-García, N., Huete-Acevedo, J., Mas‐Bargues, C., Sanz‐Ros, J., Dromant, M., & Borrás, C. (2023) · Biomolecules · doi:10.3390/biom13010165 · Cited by 28
Takaya, K., Asou, T., & Kishi, K. (2022) · GeroScience · doi:10.1007/s11357-022-00648-7 · Cited by 24
“As the removal of senescent cells by genetic manipulation improves age-related disease states [3], therapies that selectively destroy senescent cells to achieve the same goal have been reported.”
BackgroundRemodeling of tumor microenvironment by cellular senescence and immunosenescence in cervical cancer
He, Y., Qiu, Y., Yang, X., Lu, G., & Zhao, S. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.11.002 · Cited by 25
Eskiocak, O., Gewolb, J., Shah, V., Rouse, J. A., Chowdhury, S., Akyildiz, E. O., Fernández-Maestre, I., Boyer, J. A., Filliol, A. A., Harris, A. S., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-01022-w · Cited by 35
“Senescent cells accumulate with age and contribute to inflammaging and the pathophysiology of a wide range of age-related diseases 18 .”
Hypoxia‐Inducible Factor‐2α Signaling in the Skeletal System
Mendoza, S. V., Genetos, D. C., & Yellowley, C. E. (2023) · JBMR Plus · doi:10.1002/jbm4.10733 · Cited by 28
“p16-positive senescent cells even in mild proportions ( 30%) via drug-induced (AP20187) activation of INK-ATTAC—a transgene expressed in p16-positive/senescent cells that when druginduced results in targeted apoptosis—beginning at 12 months of age until the end of life, increased life span in male and female mice from…”
BackgroundCurcumin induces multiple signaling pathways leading to vascular smooth muscle cell senescence
Grabowska, W., Mosieniak, G., Achtabowska, N., Czochara, R., Litwinienko, G., Bojko, A., Sikora, E., & Bielak-Żmijewska, A. (2019) · Biogerontology · doi:10.1007/s10522-019-09825-2 · Cited by 22
Gao, R., Shi, J., Lyu, Y., Ren, B., Wei, W., Cheng, J., Chen, J., Zhou, Y., Chen, J., Sun, X., et al. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.322508 · Cited by 29
Autophagy and senescence, converging roles in pathophysiology as seen through mouse models
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2021.02.001 · Cited by 20
Song, Y., Miao, J., Qin, F., Yan, Y., Yang, J., Qin, D.-P., Hou, F. F., Zhou, L., & Cheng, Y. (2018) · Organic Letters · doi:10.1021/acs.orglett.8b02490 · Cited by 23
A dynamical systems model for the measurement of cellular senescence
Galvis, D., Walsh, D. A., Harries, L. W., Latorre, E., & Rankin, J. (2019) · Journal of The Royal Society Interface · doi:10.1098/rsif.2019.0311 · Cited by 26
Engineering mammalian cells to seek senescence-associated secretory phenotypes
Qudrat, A., Wong, J., & Truong, K. (2017) · Journal of Cell Science · doi:10.1242/jcs.206979 · Cited by 24
Eco‐evolutionary perspectives of the dynamic relationships linking senescence and cancer
Lemaître, J., Pavard, S., Giraudeau, M., Vincze, O., Jennings, G., Hamede, R., Újvári, B., & Thomas, F. (2019) · Functional Ecology · doi:10.1111/1365-2435.13394 · Cited by 22
Senolytics: A Novel Strategy for Neuroprotection in ALS?
Maximova, A., Werry, E. L., & Kassiou, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112078 · Cited by 20
Morphological changes during replicative senescence in bovine ovarian granulosa cells
Sơn, H. N., Ho, C. N. Q., Chung, Đ. C., & Long, L. T. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1624108 · Cited by 22
Cellular senescence and its impact on the circadian clock
Ahmed, R., Reza, H. M., Shinohara, K., & Nakahata, Y. (2021) · The Journal of Biochemistry · doi:10.1093/jb/mvab115 · Cited by 21
Ungvari, A., Gulej, R., Patai, R., Papp, Z., Tóth, A., Szabó, A. Á., Podesser, B. K., Sótonyi, P., Benyó, Z., Yabluchanskiy, A., et al. (2025) · GeroScience · doi:10.1007/s11357-024-01489-2 · Cited by 25
Zhou, L., Zhong, Y., Wang, F., Guo, Y., Mao, R., Xie, H., Zhang, Y., & Li, J. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.90459 · Cited by 25
The link between obesity and aging - insights into cardiac energy metabolism
Owesny, P., & Grune, T. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111870 · Cited by 25
Hornofova, T., Hubáčková, S., Uvizl, A., Kosla, J., Bártek, J., Hodný, Z., & Vašicová, P. (2019) · Aging · doi:10.18632/aging.102248 · Cited by 25
Brain macrophage senescence in glioma
Li, L., Zhang, T. C., Xiao, M., Lu, Y., & Gao, L. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.07.005 · Cited by 25
What programs the size of animal cells?
Liu, S., Tan, C., Tyers, M., Zetterberg, A., & Kafri, R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.949382 · Cited by 22
Does Modulation of an Epigenetic Clock Define a Geroprotector?
Schork, N. J., Beaulieu‐Jones, B. K., Liang, W. S., Smalley, S. L., & Goetz, L. H. (2022) · Advances in Geriatric Medicine and Research · doi:10.20900/agmr20220002 · Cited by 28
Abdul, K. S. M., Jovanović, S., & Jovanović, A. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13064 · Cited by 21
Ramos, A. M., Fernández‐Fernández, B., Pérez-Gómez, M. V., Julio, S. M. C., Sánchez-Niño, M. D., Sanz, A. B., Ruiz‐Ortega, M., & Ortíz, A. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1690450 · Cited by 25
Analysis of senescence in gingival tissues and gingival fibroblast cultures
Furukawa, M., Matsuda, K., Aoki, Y., Yamada, M., Wang, J., WATANABE, M., Kurosawa, M., Shikama, Y., & Matsushita, K. (2022) · Clinical and Experimental Dental Research · doi:10.1002/cre2.581 · Cited by 25
Guo, G., Watterson, S., Zhang, S., Bjourson, A. J., McGilligan, V., Peace, A. J., & Singh, T. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101363 · Cited by 25
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.